Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atimos versus Serevent crossover study in asthma with persistent small airways dysfunction
2013-001103-36Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of formoterol and salmeterol in asthma and allergic asthma (2 arms), sponsored by University of Dundee. Primary endpoint: Change in R5-R20 after first dose. Started Jun 2013; status: completed.
02
Drugs
formoterolsalmeterol
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2013-001103-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001103-36.